Health

BioTools Innovator Names KGI Alum Start-up Company Machine Bio as Inaugural Grand Prize Winner

Leave a comment


Startup Receives $200K Grand Prize to develop Transmembrane Protein Synthesis Platform, a technology that can produce pure protein in hours

This award represents a recognition of the need and opportunity for radical innovation in the foundational workflows of our industry and a major milestone for Machine Bio in the earliest stages of our growth.


LOS ANGELES (PRWEB)

BioTools Innovator, a new program focused on accelerating life science tools and diagnostics, announced Machine Bio as the grand prize winner of the first BioTools Innovator program final competition. The winning company was determined by a live audience vote on Oct. 14 at the BioTools Innovator Capstone Event in Carlsbad, CA.

Machine Bio, a life science startup based in Claremont, CA and founded by Keck Graduate Institute (KGI) alumni, is developing the Transmembrane Protein Synthesis Platform, a technology that can produce pure protein in hours.

“Machine Bio’s mission is to develop and commercialize a transformative protein expression platform that drastically minimizes the process of making pure protein to a single step,” said KGI alum David Marash, founder and CEO of Machine Bio. “This award represents a recognition of the need and opportunity for radical innovation in the foundational workflows of our industry and a major milestone for Machine Bio in the earliest stages of our growth. We are extremely grateful to the BioTools Innovator community for supporting the development of our company and facilitating our integration into the broader biotech tools community as we work towards our vision of a streamlined biotech industry in which the value of engineered protein is delivered to society on a grander scale.”

BioTools Innovator received over 160 applications in this year’s cycle. Twenty-three companies were invited to pitch during the BioTools Innovator Road Tour, with 10 companies ultimately receiving a slot in the 2021 Cohort. Machine Bio is the recipient of the $200,000 grand prize which will be used to advance its business goals and objectives.

“It is exciting to name Machine Bio as the first winner of our BioTools Accelerator program,” said Kathryn Zavala, managing director of BioTools Innovator. “Machine Bio is developing a product with the potential to dramatically speed up protein synthesis which may have many downstream benefits in such areas as drug development and therapeutic manufacturing. I am thrilled to see their hard work recognized. The goal of the BioTools Innovator program is to advance life science tools innovation and this award will make a significant impact in helping this early-stage company reach their next milestone.”

Machine Bio participated in the BioTools Innovator 2021 Accelerator program, which provides early-stage companies with in-depth, customized mentorship from key leaders in the life science and diagnostics industries, exclusive virtual networking opportunities and workshops, and high profile visibility to investors, strategic corporates, and potential customers.

Share article on social media or email:

Leave a Reply